Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Targeted therapies: sunitinib in RCC-expanded access equals expanded benefit?

Targeted therapies: sunitinib in RCC-expanded access equals expanded benefit? Nat Rev Clin Oncol. 2009 Dec; 6(12):679-80.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.